(Q70229140)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6334287%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

title

The pathogenesis, diagnosis, and treatment of histiocytosis syndromes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6334287%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

The Pathogenesis, Diagnosis, and Treatment of Histiocytosis Syndromes (English)

1 reference

https://api.crossref.org/works/10.1111/J.1525-1470.1983.TB01101.X

1 October 2023

1 reference

https://api.crossref.org/works/10.1111/J.1525-1470.1983.TB01101.X

1 October 2023

author name string

J. M. Lipton

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6334287

1 October 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6334287

1 October 2023

publication date

1 October 1983

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6334287%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

9 October 2019

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1525-1470.1983.tb01101.x

1 reference

https://api.crossref.org/works/10.1111/J.1525-1470.1983.TB01101.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1525-1470.1983.tb01101.x/fullpdf

1 October 2023

1 reference

https://api.crossref.org/works/10.1111/J.1525-1470.1983.TB01101.X

1 October 2023

published in

Pediatric Dermatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6334287%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

volume

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6334287%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6334287%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

page(s)

112-120

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6334287%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

2

1 reference

https://api.crossref.org/works/10.1111/J.1525-1470.1983.TB01101.X

1 October 2023

Histiocytosis-X

3

1 reference

https://api.crossref.org/works/10.1111/J.1525-1470.1983.TB01101.X

The histiocytic disorders: a pathophysiologic analysis

1 October 2023

12

1 reference

https://api.crossref.org/works/10.1111/J.1525-1470.1983.TB01101.X

Regulation of granulopoiesis

1 October 2023

13

1 reference

https://api.crossref.org/works/10.1111/J.1525-1470.1983.TB01101.X

1 October 2023

Federation Proceedings

14

34

2272

Stanley ER

1975

1 reference

https://api.crossref.org/works/10.1111/J.1525-1470.1983.TB01101.X

A review and reevaluation of the histiocytic disorders

1 October 2023

16

1 reference

https://api.crossref.org/works/10.1111/J.1525-1470.1983.TB01101.X

Bone Marrow Origin of Hepatic Macrophages (Kupffer Cells) in Humans

1 October 2023

19

1 reference

https://api.crossref.org/works/10.1111/J.1525-1470.1983.TB01101.X

Direct evidence for a bone marrow origin of the alveolar macrophage in man

1 October 2023

20

1 reference

https://api.crossref.org/works/10.1111/J.1525-1470.1983.TB01101.X

Intravascular phagocytosis in the rabbit bone marrow: a possible fate of normal senescent red cells

1 October 2023

21

1 reference

https://api.crossref.org/works/10.1111/J.1525-1470.1983.TB01101.X

Osteoclasts derived from haematopoietic stem cells

1 October 2023

22

1 reference

https://api.crossref.org/works/10.1111/J.1525-1470.1983.TB01101.X

Epidermal Langerhans cells are derived from cells originating in bone marrow

1 October 2023

26

1 reference

https://api.crossref.org/works/10.1111/J.1525-1470.1983.TB01101.X

Origins of cancer in the neonate

1 October 2023

30

1 reference

https://api.crossref.org/works/10.1111/J.1525-1470.1983.TB01101.X

1 October 2023

37

51

542

Carlson RA

1976

1 reference

https://api.crossref.org/works/10.1111/J.1525-1470.1983.TB01101.X

Histiocytosis X—an analysis of prognostic factors

1 October 2023

39

1 reference

https://api.crossref.org/works/10.1111/J.1525-1470.1983.TB01101.X

Results of treatment of 127 patients with systemic histiocytosis

1 October 2023

40

1 reference

https://api.crossref.org/works/10.1111/J.1525-1470.1983.TB01101.X

Disseminated histiocytosis X.Analysis of prognostic factors based on a retrospective study of 50 cases

1 October 2023

41

1 reference

https://api.crossref.org/works/10.1111/J.1525-1470.1983.TB01101.X

A staging system for histiocytosis X: a Southwest Oncology Group Study

1 October 2023

42

1 reference

https://api.crossref.org/works/10.1111/J.1525-1470.1983.TB01101.X

The course and prognosis of reticuloendotheliosis (eosinophilic granuloma, Schüller-Christian disease and Letterer-Siwe disease); a study of forty cases

1 October 2023

46

1 reference

https://api.crossref.org/works/10.1111/J.1525-1470.1983.TB01101.X

Histiocytosis X: role of radiation therapy in management with special reference to dose levels employed

1 October 2023

47

1 reference

https://api.crossref.org/works/10.1111/J.1525-1470.1983.TB01101.X

Radiation therapy in patients with histiocytosis: management of diabetes insipidus and bone lesions

1 October 2023

48

1 reference

https://api.crossref.org/works/10.1111/J.1525-1470.1983.TB01101.X

Therapy of histiocytosis X with vincristine, vinblastine, and cyclophosphamide. The Southwest Cancer Chemotherapy Study Group

1 October 2023

50

1 reference

https://api.crossref.org/works/10.1111/J.1525-1470.1983.TB01101.X

Histiocytosis X--comparison of three treatment regimens

1 October 2023

51

1 reference

https://api.crossref.org/works/10.1111/J.1525-1470.1983.TB01101.X

1 October 2023

Cancer Treatment Reports

52

63

2125

Komp DM

1979

1 reference

https://api.crossref.org/works/10.1111/J.1525-1470.1983.TB01101.X

Chemotherapy of reticuloendotheliosis:Comparison of methotrexate plus prednisone vs. vincristine plus prednisone

1 October 2023

53

1 reference

https://api.crossref.org/works/10.1111/J.1525-1470.1983.TB01101.X

Combination Chemotherapy in Histiocytosis X

1 October 2023

54

1 reference

https://api.crossref.org/works/10.1111/J.1525-1470.1983.TB01101.X

Chlorambucil in histiocytosis X: a Southwest Oncology Group study

1 October 2023

55

1 reference

https://api.crossref.org/works/10.1111/J.1525-1470.1983.TB01101.X

Histiocytosis X: Clinical trial of chlorambucil: A report from childrens cancer study group

1 October 2023

56

1 reference

https://api.crossref.org/works/10.1111/J.1525-1470.1983.TB01101.X

The treatment of advanced histiocytosis- X with sequential hemibody irradiation

1 October 2023

57

1 reference

https://api.crossref.org/works/10.1111/J.1525-1470.1983.TB01101.X

1 October 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6334287%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

1 reference